377 related articles for article (PubMed ID: 9502419)
1. Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6.
Crosby HA; Hubscher S; Fabris L; Joplin R; Sell S; Kelly D; Strain AJ
Am J Pathol; 1998 Mar; 152(3):771-9. PubMed ID: 9502419
[TBL] [Abstract][Full Text] [Related]
2. Immunolocalization of OV-6, a putative progenitor cell marker in human fetal and diseased pediatric liver.
Crosby HA; Hubscher SG; Joplin RE; Kelly DA; Strain AJ
Hepatology; 1998 Oct; 28(4):980-5. PubMed ID: 9755234
[TBL] [Abstract][Full Text] [Related]
3. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
Sakisaka S; Kawaguchi T; Taniguchi E; Hanada S; Sasatomi K; Koga H; Harada M; Kimura R; Sata M; Sawada N; Mori M; Todo S; Kurohiji T
Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis.
Adams DH; Hubscher SG; Shaw J; Johnson GD; Babbs C; Rothlein R; Neuberger JM
Hepatology; 1991 Sep; 14(3):426-31. PubMed ID: 1714872
[TBL] [Abstract][Full Text] [Related]
5. Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: an immunohistochemical study.
Tsuneyama K; Harada K; Yasoshima M; Kaji K; Gershwin ME; Nakanuma Y
J Pathol; 1998 Oct; 186(2):126-30. PubMed ID: 9924426
[TBL] [Abstract][Full Text] [Related]
6. Hepatic Stem/Progenitor Cell Activation Differs between Primary Sclerosing and Primary Biliary Cholangitis.
Carpino G; Cardinale V; Folseraas T; Overi D; Floreani A; Franchitto A; Onori P; Cazzagon N; Berloco PB; Karlsen TH; Alvaro D; Gaudio E
Am J Pathol; 2018 Mar; 188(3):627-639. PubMed ID: 29248458
[TBL] [Abstract][Full Text] [Related]
7. Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis.
Broomé U; Hultcrantz R; Scheynius A
Scand J Gastroenterol; 1993 Feb; 28(2):126-30. PubMed ID: 8095102
[TBL] [Abstract][Full Text] [Related]
8. Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction.
Chen Y; Guldiken N; Spurny M; Mohammed HH; Haybaeck J; Pollheimer MJ; Fickert P; Gassler N; Jeon MK; Trautwein C; Strnad P
J Pathol; 2015 Nov; 237(3):343-54. PubMed ID: 26108453
[TBL] [Abstract][Full Text] [Related]
9. Identification of bipotential progenitor cells in human liver development.
Haruna Y; Saito K; Spaulding S; Nalesnik MA; Gerber MA
Hepatology; 1996 Mar; 23(3):476-81. PubMed ID: 8617427
[TBL] [Abstract][Full Text] [Related]
10. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis.
Chung BK; Guevel BT; Reynolds GM; Gupta Udatha DB; Henriksen EK; Stamataki Z; Hirschfield GM; Karlsen TH; Liaskou E
J Autoimmun; 2017 Feb; 77():45-54. PubMed ID: 27784538
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis.
Tinmouth J; Lee M; Wanless IR; Tsui FW; Inman R; Heathcote EJ
Liver; 2002 Jun; 22(3):228-34. PubMed ID: 12100573
[TBL] [Abstract][Full Text] [Related]
12. A cytokeratin immunohistochemical study of cholestatic liver disease: evidence that hepatocytes can express 'bile duct-type' cytokeratins.
Van Eyken P; Sciot R; Desmet VJ
Histopathology; 1989 Aug; 15(2):125-35. PubMed ID: 2476370
[TBL] [Abstract][Full Text] [Related]
13. Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis.
Tsuneyama K; Yasoshima M; Harada K; Hiramatsu K; Gershwin ME; Nakanuma Y
Hepatology; 1998 Sep; 28(3):620-3. PubMed ID: 9731549
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis.
Alvaro D; Invernizzi P; Onori P; Franchitto A; De Santis A; Crosignani A; Sferra R; Ginanni-Corradini S; Mancino MG; Maggioni M; Attili AF; Podda M; Gaudio E
J Hepatol; 2004 Dec; 41(6):905-12. PubMed ID: 15645536
[TBL] [Abstract][Full Text] [Related]
15. Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis.
Sasatomi K; Noguchi K; Sakisaka S; Sata M; Tanikawa K
J Hepatol; 1998 Sep; 29(3):409-16. PubMed ID: 9764987
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study on phenotypical changes of hepatocytes in liver disease with reference to extracellular matrix composition.
Matsumoto S; Yamamoto K; Nagano T; Okamoto R; Ibuki N; Tagashira M; Tsuji T
Liver; 1999 Feb; 19(1):32-8. PubMed ID: 9928763
[TBL] [Abstract][Full Text] [Related]
17. Induced expression of heat-shock protein on biliary epithelium in patients with primary sclerosing cholangitis and primary biliary cirrhosis.
Broomé U; Scheynius A; Hultcrantz R
Hepatology; 1993 Aug; 18(2):298-303. PubMed ID: 8340058
[TBL] [Abstract][Full Text] [Related]
18. Morphometric and immunohistochemical characterization of human liver regeneration.
Rubin EM; Martin AA; Thung SN; Gerber MA
Am J Pathol; 1995 Aug; 147(2):397-404. PubMed ID: 7639333
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of langerhans cell infiltrate by CD1a immunostain in liver biopsy for the diagnosis of primary biliary cirrhosis.
Graham RP; Smyrk TC; Zhang L
Am J Surg Pathol; 2012 May; 36(5):732-6. PubMed ID: 22498823
[TBL] [Abstract][Full Text] [Related]
20. Peribiliary vascular plexus in primary sclerosing cholangitis and primary biliary cirrhosis.
Washington K; Clavien PA; Killenberg P
Hum Pathol; 1997 Jul; 28(7):791-5. PubMed ID: 9224746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
